Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Thomas Jefferson University
Mayo Clinic
NRG Oncology
NRG Oncology
University of Washington
City of Hope Medical Center
Mayo Clinic
Jonsson Comprehensive Cancer Center
NRG Oncology
City of Hope Medical Center
University of Southern California
Assistance Publique - Hôpitaux de Paris
British Columbia Cancer Agency
AHS Cancer Control Alberta
Case Comprehensive Cancer Center